key: cord-0948851-n5b9p34m
authors: Bibby, Kyle; Bivins, Aaron; Wu, Zhenyu; North, Devin
title: Making Waves: Plausible Lead Time for Wastewater Based Epidemiology as an Early Warning System for COVID-19
date: 2021-07-12
journal: Water Res
DOI: 10.1016/j.watres.2021.117438
sha: 86b96466e9b2dd0af4c556a7293ed84885ab2954
doc_id: 948851
cord_uid: n5b9p34m

Wastewater-based epidemiology (WBE) has emerged as a useful tool in the fight to track and contain COVID-19 spread within communities. One of the motives behind COVID-19 WBE efforts is the potential for ‘early warning’ of either the onset of disease in a new setting or changes in trends in communities where disease is endemic. Many initial reports of the early warning potential of WBE have relied upon retrospective sample analysis, and delays in WBE analysis and reporting should be considered when evaluating the early warning potential of WBE that enable public health action. Our purpose in this manuscript is to establish a framework to critique the potential of WBE to serve as an early warning system, with special attention to the onset of viral shedding and the differential between results reporting for WBE and clinical testing. While many uncertainties remain regarding both COVID-19 clinical presentation and technical factors influencing WBE results, our analysis suggests at most a modest lead time interval ranging from six days for clinical testing to four days for WBE during community-level wastewater surveillance where clinical testing is accessible on-demand with a rapid time to results. This potential lead time for WBE subsequently increases in settings with limited clinical testing capacity or utilization. Care should be taken when reporting ‘early detection’ of COVID-19 disease trends via WBE to consider underlying causes (e.g., clinical testing lag or delayed result reporting) to avoid misrepresenting WBE potential.

Wastewater-based epidemiology (WBE) has emerged as a useful tool in the fight to 30 track and contain COVID-19 spread within communities. One of the motives behind 31 COVID-19 WBE efforts is the potential for "early warning" of either the onset of disease in 32 a new setting or changes in trends in communities where disease is endemic. Many 33 initial reports of the early warning potential of WBE have relied upon retrospective 34 sample analysis, and delays in WBE analysis and reporting should be considered when 35 evaluating the early warning potential of WBE that enable public health action. Our 36 purpose in this manuscript is to establish a framework to critique the potential of WBE to 37 serve as an early warning system, with special attention to the onset of viral shedding 38 and the differential between results reporting for WBE and clinical testing. While many 39 uncertainties remain regarding both COVID-19 clinical presentation and technical factors 40 influencing WBE results, our analysis suggests at most a modest lead time interval 41 ranging from six days for clinical testing to four days for WBE during community-level 42 wastewater surveillance where clinical testing is accessible on-demand with a rapid time 43

to results. This potential lead time for WBE subsequently increases in settings with 44 limited clinical testing capacity or utilization. Care should be taken when reporting "early 45 detection" of COVID-19 disease trends via WBE to consider underlying causes (e.g., 46

clinical testing lag or delayed result reporting) to avoid misrepresenting WBE potential. Wastewater-Based Epidemiology to Monitor COVID-19 50

As SARS-CoV-2 is excreted in body fluids, such as urine and feces, wastewater-based 51 epidemiology (WBE; also termed wastewater surveillance or wastewater monitoring) has 52 been used globally to monitor public health on a community-wide scale. Compared to 53 individual testing, wastewater provides an aggregated, anonymous, and non-invasive 54 testing opportunity. In WBE applications to monitor COVID-19, the presence and/or 55 Here, we consider the factors influencing the potential of WBE to serve as an early 85 warning system of disease trends and establish the constraints around when it may 86 serve this role. 87 88

The goal of the current analysis is to establish a simplified framework to critique the early have been less well reported. Importantly, many WBE results are "back dated" to 107 sampled collection date during trend analysis without further consideration of sample 108 processing time (i.e., when the result was actually reported). This reporting differential is 109 critical for WBE results to provide an actionable lead time. 110

The second early detection factor is the excretion of SARS-CoV-2 RNA in the 111 stool of infected individuals prior to either nasal viral shedding or symptom onset, and 112 the subsequent clinical detection. In this instance, wastewater monitoring has the 113 potential to detect COVID-19 cases before it would be likely for these cases to be 114 clinically detected. increments. In this sampling scheme, subsamples collected early in the 24-hour 133 collection period will be further delayed by this compositing period prior to analysis. 134

Following collection, samples may need to be shipped from the collection site to the 135 laboratory, adding additional delay prior to analysis. Considering all of these factors, the 136 period between initial viral excretion and sample receipt by the analysis laboratory may 137 be as high as two or more days in current sample collection workflows. We note that 138 there is potential viral RNA decay as well during sample collection and transport, so in 139 addition to delaying sample reporting this delay may also alter reporting accuracy 140 onset. This is consistent with a recent meta-analysis by Miura et al. (Miura, Kitajima, and 198 Omori 2021), which determined that both the incidence and load of viral shedding in 199 stool increased after initial symptom presentation. We note that differing methods may 200 be applied to quantify viral loads in stool and nasal swabs, with the potential for differing 201 conflating factors such as the presence of PCR inhibitors. However, taken together, the 202 evidence suggests that human viral shedding in stool is unlikely to precede symptoms 203 on a timescale of weeks and that viral stool shedding load increases following the onset 204 of symptoms in symptomatic cases. 205

Finally, we note that there are likely individual exceptions to the trends we outline 206 above, especially within human populations. However, as wastewater monitoring is 207 intended to be a community-level tool, rare individual variations (e.g., early fecal 208 shedding) are not expected to be significant contributors to wastewater as an early 209 warning tool. 210 211

As discussed above, the potential for wastewater monitoring to provide early warning 213 depends on both viral shedding dynamics and differentials in clinical and WBE testing 214 and reporting. In Figure 1 , we consider the relative differentials under various shedding 215 and reporting scenarios as discussed above. The x-axis of Figure 1 is divided into two 216 parts. One denotes the onset of symptoms one to four days before fecal SARS-CoV-2 217 RNA shedding while the other denotes the onset of fecal shedding one to four days 218 before symptoms. The y-axis is the reporting time differential between WBE and clinical 219 testing results and is also divided into two partsone with WBE results leading clinical 220 results by one to four days and the other with clinical results leading WBE results by one 221 to four days. Importantly, application of this framework should include relevant ranges 222 rather than specific values for a specific scenario to reflect the uncertainty associated 223 with varying community-level WBE applications. 224

Restricting this analysis to a representative range of both viral shedding and 225 clinical/WBE testing results differential is a useful exercise to consider the potential of 226 WBE as an early warning tool. Based upon available shedding data, we consider the 227 range of plausible scenarios as initial viral shedding in stool two days preceding 228 symptom onset to three days following symptom onset per observations from COVID-19 229 patients and animal models. We then consider a scenario where a clinical test is 230 administered at symptom onset, and clinical testing results are reported within zero to 231 three days of collection. As described above, a representative range of WBE reporting 232 times is one to three days from initial signal excretion. In this case, the reporting 233 differential between clinical and WBE testing would range between a two day lead for 234 WBE (i.e., WBE results reported one day following RNA stool shedding) to a four day 235 lead for clinical testing (i.e., WBE results reported seven days following stool shedding). 236

Considering both the plausible stool shedding trends and reporting differential 237 (highlighted in the green box on Figure 1 ), the reasonable range of "early detection" 238 would be from a four-day lead time for WBE to a six-day lead time for clinical testing, 239 limiting the possibility of longer early warning periods via WBE under this idealized 240 scenario. It should be noted that for asymptomatic infections the onset of RNA stool 241 shedding relative to symptoms would be unbounded toward the right side of the x-axis. 242

In situations where asymptomatic infections are prevalent and unlikely to be detected by 243 clinical surveillance, WBE could be capable of longer lead times for early detection. 244

Implicit to this analysis are the assumptions that clinical testing is widely 245 available, and that the population is willing to be tested. The reporting advantage of 246 WBE would likely increase as clinical testing is less available and/or unutilized. In 247 addition, this idealized analysis assumes that RNA stool shedding is detected via 248 wastewater without error; false negatives and false positives are an additional concern to 249 be considered when interpreting any disease monitoring approach, including WBE. In 250 addition, this analysis assumes that the major SARS-CoV-2 RNA source in WBE 251 applications is stool, which remains to be confirmed. A final consideration is the 252 performance of asymptomatic surveillance testing, i.e., random individual testing in the 253 absence of symptoms. Under such a surveillance testing scenario, where asymptomatic 254 cases are much more likely to be discovered, advantages in wastewater detection for 255 early warning will likely decrease, especially when surveillance testing is analyzed and 256 The x-axis represents the onset of symptoms relative to the onset of RNA shedding in 261

stool (e.g., +4 equates to RNA stool shedding 4 days after symptom onset); the y-axis 262 represents the differential in time to results between WBE and clinical testing. 

SARS-CoV-2 RNA Monitoring in Wastewater as a 300 Potential Early Warning System for COVID-19 Transmission in the Community: A 301

Decay of SARS-CoV-2 and surrogate murine 304 hepatitis virus RNA in untreated wastewater to inform application in wastewater-305 based epidemiology

Wastewater-Based Epidemiology: Global 308

Collaborative to Maximize Contributions in the Fight Against COVID-19

Persistence of SARS-CoV-2 312 in water and wastewater

Catching a Resurgence: 316 Increase in SARS-CoV-2 Viral RNA

Clinical Tests and 96 H before Hospitalizations

Quantitative Analysis of SARS-CoV-2 321 RNA from Wastewater Solids in Communities with Low COVID-19 Incidence and 322 Prevalence

Wastewater Surveillance for Population-Wide Covid-19: 324 The Present and Future

SARS-CoV-2 Infection of 328

African Green Monkeys Results in Mild Respiratory Disease Discernible by PET/CT 329 Imaging and Shedding of Infectious Virus from Both Respiratory and 330 Gastrointestinal Tracts

CoV-2 Detection Enables Forecasting of Community Infection 334 Dynamics in San Diego County

Unravelling the Early Warning Capability of Wastewater Surveillance for COVID-19: 338 A Temporal Study on SARS-CoV-2 RNA Detection and Need for the Escalation

Evaluating Recovery

Throughput of Different Concentration Methods for SARS-CoV-2

Wastewater-Based Epidemiology

Xinbin Feng, and Hua Zhang. 2020. 345 "The Potential of Wastewater-Based Epidemiology as Surveillance and Early 346 Warning of Infectious Disease Outbreaks

Presence of SARS-Coronavirus-2 RNA in Sewage and Correlation with 350

Reported COVID-19 Prevalence in the Early Stage of the Epidemic in The 351 Netherlands

Duration of SARS-CoV-2 353

Viral Shedding in Faeces as a Parameter for Wastewater-Based Epidemiology: Re-354 Analysis of Patient Data Using a Shedding Dynamics Model

Show Us the Data: 358 Global COVID-19 Wastewater Monitoring Efforts, Equity, and Gaps

Measurement of 362 SARS-CoV-2 RNA in Wastewater Tracks Community Infection Dynamics

Pilar Domingo-Calap, and 365 Gloria Sánchez. 2020

Epidemiological Surveillance

SARS-CoV-2 RNA in Wastewater Anticipated COVID-370 19 Occurrence in a Low Prevalence Area

Novel Wastewater Surveillance Strategy for 374

Current Opinion in Environmental Science 375 & Health

Virological Assessment of 378 Hospitalized Patients with COVID-2019

African Green Monkey Model for COVID-19 and Protection against Re-Infection

Wastewater-Based Epidemiology for Early 384 Detection of Viral Outbreaks